Skylight Health just announced that they’ve begun trading on the OTCQX and have received DTC Eligibility under $SLHGF. This means that the company will now have more transparency and will be more visible for US investors to invest in the company.
https://ca.finance.yahoo.com/news/skylight-health-announces-trading-otcqx-110000409.html
$SLHG.V is revolutionizing the healthcare industry with their tech-enhanced offerings and aggressive acquisition strategy. With 32 clinics under their belt, $SLHG.V’s platform helps optimize processes at these clinics to reduce costs and increase efficiency. This is done through value-based care where national resources/collaboration are made available to individual clinics under $SLHG.V’s belt. This ability is essential when considering the potential to maximize clinic profitability. The company has numerous reasons behind their growth.
- Forecasted $70M revenue run rate and breakeven EBITDA by the end of 2022.
- Strong organic and acquisition growth to maximize operations.
- An extremely solid management team with a diverse range of experiences.
The company has only a 0.82 P/S ratio at a market cap of just $21M. There’s definitely significant room for the company to grow, and as they continue to grow rapidly, the current valuation seems extremely undervalued.